Fundz

Metagenomi Inks $175M Series B

PUBLIC · MGXJan 26, 2022

Amount Raised

$175 Million

Round Type

Series B

EmeryvilleInformation TechnologyBiotechnology

Description

Metagenomi, a genetic medicines company, has raised $175 million in Series B financing.

Quick answer

Metagenomi Therapeutics, Inc. raised $175 Million in a Series B round, dated January 26, 2022. Metagenomi Therapeutics, Inc. is based in Emeryville, California, United States.

How much did Metagenomi Therapeutics, Inc. raise?
Metagenomi Therapeutics, Inc. raised $175 Million in a Series B round on January 26, 2022.
What does Metagenomi Therapeutics, Inc. do?
Gene editing is changing the world.
Where is Metagenomi Therapeutics, Inc. based and how big is it?
Metagenomi Therapeutics, Inc. is based in Emeryville, California, United States.
Who are the decision-makers at Metagenomi Therapeutics, Inc?
Fundz holds 1 contact at Metagenomi Therapeutics, Inc., including the President & COO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Metagenomi Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Satellite Biosciences, Inc. raised $82M on March 11, 2022.
  • BCD Bioscience, Inc. raised $12M on March 11, 2022.
  • RIGImmune raised $5K (Pre-Seed) on March 11, 2022.
  • NOULA HEALTH CO. raised $1.1M (Seed) on March 10, 2022.
  • GelMEDIX raised an undisclosed amount on March 10, 2022.
  • Nabgen, Inc. raised $100K (Pre-Seed) on March 10, 2022.

Who to call at Metagenomi Therapeutics, Inc., and when

A new round usually means Metagenomi Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Metagenomi Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Metagenomi Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Metagenomi Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Metagenomi Therapeutics, Inc.

Location

1545 Park Avenue

Emeryville, California, United States

About

Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Metagenomi Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJian I., President & COO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Metagenomi Therapeutics, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Metagenomi Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.